201 related articles for article (PubMed ID: 15231656)
1. DNA hypomethylation and ovarian cancer biology.
Widschwendter M; Jiang G; Woods C; Müller HM; Fiegl H; Goebel G; Marth C; Müller-Holzner E; Zeimet AG; Laird PW; Ehrlich M
Cancer Res; 2004 Jul; 64(13):4472-80. PubMed ID: 15231656
[TBL] [Abstract][Full Text] [Related]
2. DNA hypomethylation is prevalent even in low-grade breast cancers.
Jackson K; Yu MC; Arakawa K; Fiala E; Youn B; Fiegl H; Müller-Holzner E; Widschwendter M; Ehrlich M
Cancer Biol Ther; 2004 Dec; 3(12):1225-31. PubMed ID: 15539937
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.
Ehrlich M; Woods CB; Yu MC; Dubeau L; Yang F; Campan M; Weisenberger DJ; Long T; Youn B; Fiala ES; Laird PW
Oncogene; 2006 Apr; 25(18):2636-45. PubMed ID: 16532039
[TBL] [Abstract][Full Text] [Related]
4. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential.
Qu G; Dubeau L; Narayan A; Yu MC; Ehrlich M
Mutat Res; 1999 Jan; 423(1-2):91-101. PubMed ID: 10029684
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer.
Zeimet AG; Fiegl H; Goebel G; Kopp F; Allasia C; Reimer D; Steppan I; Mueller-Holzner E; Ehrlich M; Marth C
Gynecol Oncol; 2011 Apr; 121(1):24-31. PubMed ID: 21251700
[TBL] [Abstract][Full Text] [Related]
6. Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer.
Grunau C; Sanchez C; Ehrlich M; van der Bruggen P; Hindermann W; Rodriguez C; Krieger S; Dubeau L; Fiala E; De Sario A
Genes Chromosomes Cancer; 2005 May; 43(1):11-24. PubMed ID: 15704127
[TBL] [Abstract][Full Text] [Related]
7. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16.
Qu GZ; Grundy PE; Narayan A; Ehrlich M
Cancer Genet Cytogenet; 1999 Feb; 109(1):34-9. PubMed ID: 9973957
[TBL] [Abstract][Full Text] [Related]
8. Satellite DNA hypomethylation in karyotyped Wilms tumors.
Ehrlich M; Hopkins NE; Jiang G; Dome JS; Yu MC; Woods CB; Tomlinson GE; Chintagumpala M; Champagne M; Dillerg L; Parham DM; Sawyer J
Cancer Genet Cytogenet; 2003 Mar; 141(2):97-105. PubMed ID: 12606126
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.
Notaro S; Reimer D; Fiegl H; Schmid G; Wiedemair A; Rössler J; Marth C; Zeimet AG
BMC Cancer; 2016 Aug; 16():589. PubMed ID: 27485273
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of pericentromeric DNA in breast adenocarcinomas.
Narayan A; Ji W; Zhang XY; Marrogi A; Graff JR; Baylin SB; Ehrlich M
Int J Cancer; 1998 Sep; 77(6):833-8. PubMed ID: 9714050
[TBL] [Abstract][Full Text] [Related]
11. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.
Wong N; Lam WC; Lai PB; Pang E; Lau WY; Johnson PJ
Am J Pathol; 2001 Aug; 159(2):465-71. PubMed ID: 11485905
[TBL] [Abstract][Full Text] [Related]
13. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication.
Hassan KM; Norwood T; Gimelli G; Gartler SM; Hansen RS
Hum Genet; 2001 Oct; 109(4):452-62. PubMed ID: 11702227
[TBL] [Abstract][Full Text] [Related]
14. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
15. A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in others.
Nishiyama R; Qi L; Tsumagari K; Weissbecker K; Dubeau L; Champagne M; Sikka S; Nagai H; Ehrlich M
Cancer Biol Ther; 2005 Apr; 4(4):440-8. PubMed ID: 15846090
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2.
Kondo T; Bobek MP; Kuick R; Lamb B; Zhu X; Narayan A; Bourc'his D; Viegas-Péquignot E; Ehrlich M; Hanash SM
Hum Mol Genet; 2000 Mar; 9(4):597-604. PubMed ID: 10699183
[TBL] [Abstract][Full Text] [Related]
17. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.
Woloszynska-Read A; Zhang W; Yu J; Link PA; Mhawech-Fauceglia P; Collamat G; Akers SN; Ostler KR; Godley LA; Odunsi K; Karpf AR
Clin Cancer Res; 2011 Apr; 17(8):2170-80. PubMed ID: 21296871
[TBL] [Abstract][Full Text] [Related]
18. Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression.
Keita M; Wang ZQ; Pelletier JF; Bachvarova M; Plante M; Gregoire J; Renaud MC; Mes-Masson AM; Paquet ÉR; Bachvarov D
Gynecol Oncol; 2013 Feb; 128(2):356-63. PubMed ID: 23219462
[TBL] [Abstract][Full Text] [Related]
19. Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma.
Dammann RH; Kirsch S; Schagdarsurengin U; Dansranjavin T; Gradhand E; Schmitt WD; Hauptmann S
Int J Oncol; 2010 Jan; 36(1):171-9. PubMed ID: 19956846
[TBL] [Abstract][Full Text] [Related]
20. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements.
Ehrlich M
J Nutr; 2002 Aug; 132(8 Suppl):2424S-2429S. PubMed ID: 12163705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
